Short-Term Outcomes of PreserFlo for Secondary Glaucoma after Combined Descemet Stripping Automated Endothelial Keratoplasty and Artificial Iris-Intraocular Lens Implantation: A Case Report.
{"title":"Short-Term Outcomes of PreserFlo for Secondary Glaucoma after Combined Descemet Stripping Automated Endothelial Keratoplasty and Artificial Iris-Intraocular Lens Implantation: A Case Report.","authors":"Shmuel Kagasov, Irit Bahar, Noa Geffen, Alon Zahavi","doi":"10.1159/000552960","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Secondary glaucoma following combined corneal transplantation and artificial iris-intraocular lens (IOL) complex implantation represents a significant therapeutic challenge. Reports of surgical management in such complex eyes remain limited. We report a case of successful PreserFlo MicroShunt implantation for the management of secondary glaucoma following combined Descemet stripping automated endothelial keratoplasty (DSAEK) and Reper artificial iris-IOL complex implantation.</p><p><strong>Case presentation: </strong>A 54-year-old woman with a history of right eye corneal perforation resulting in aphakia underwent combined DSAEK and Reper artificial iris-IOL complex implantation (Reper-NN LTD, Nizhny Novgorod, Russia). Six months after surgery, she developed secondary glaucoma with intraocular pressure (IOP) elevation to 30 mm Hg despite maximal tolerated medical therapy, accompanied by optic disc cupping, retinal nerve fiber layer thinning, and corresponding visual field defects. PreserFlo MicroShunt implantation was performed. Postoperatively, IOP decreased to 6 mm Hg with a well-functioning filtering bleb, and the corneal graft remained clear throughout the 3-month follow-up.</p><p><strong>Conclusion: </strong>To our knowledge, this is the first report describing PreserFlo MicroShunt implantation for secondary glaucoma following combined Reper artificial iris-IOL implantation and endothelial keratoplasty. This case highlights the potential role of PreserFlo as a surgical option for IOP control in highly complex anterior segment eyes.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"17 1","pages":"764-770"},"PeriodicalIF":0.6000,"publicationDate":"2026-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13427325/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000552960","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Secondary glaucoma following combined corneal transplantation and artificial iris-intraocular lens (IOL) complex implantation represents a significant therapeutic challenge. Reports of surgical management in such complex eyes remain limited. We report a case of successful PreserFlo MicroShunt implantation for the management of secondary glaucoma following combined Descemet stripping automated endothelial keratoplasty (DSAEK) and Reper artificial iris-IOL complex implantation.
Case presentation: A 54-year-old woman with a history of right eye corneal perforation resulting in aphakia underwent combined DSAEK and Reper artificial iris-IOL complex implantation (Reper-NN LTD, Nizhny Novgorod, Russia). Six months after surgery, she developed secondary glaucoma with intraocular pressure (IOP) elevation to 30 mm Hg despite maximal tolerated medical therapy, accompanied by optic disc cupping, retinal nerve fiber layer thinning, and corresponding visual field defects. PreserFlo MicroShunt implantation was performed. Postoperatively, IOP decreased to 6 mm Hg with a well-functioning filtering bleb, and the corneal graft remained clear throughout the 3-month follow-up.
Conclusion: To our knowledge, this is the first report describing PreserFlo MicroShunt implantation for secondary glaucoma following combined Reper artificial iris-IOL implantation and endothelial keratoplasty. This case highlights the potential role of PreserFlo as a surgical option for IOP control in highly complex anterior segment eyes.
摘要：联合角膜移植和人工虹膜-人工晶状体（IOL）复合体植入术后继发性青光眼是一项重大的治疗挑战。这种复杂眼睛的手术治疗报告仍然有限。我们报告一例成功的PreserFlo MicroShunt植入术治疗继发性青光眼后联合Descemet剥离自动内皮角膜移植术（DSAEK）和Reper人工虹膜- iol复合物植入术。病例介绍：一名54岁女性，右眼角膜穿孔导致无晶状体，行DSAEK联合Reper人工虹膜-人工晶体复合植入术（Reper- nn LTD, Nizhny Novgorod, Russia）。术后6个月，患者发生继发性青光眼，尽管接受了最大限度的耐受性药物治疗，但眼压（IOP）升高至30 mm Hg，并伴有视盘拔罐，视网膜神经纤维层变薄，以及相应的视野缺损。进行PreserFlo MicroShunt植入。术后，IOP降至6 mm Hg，滤过泡功能良好，角膜移植物在3个月的随访中保持清晰。结论：据我们所知，这是第一次报道PreserFlo MicroShunt植入术治疗Reper人工虹膜- iol联合角膜内皮移植术后继发性青光眼。本病例强调了PreserFlo作为高度复杂的前段眼控制IOP的手术选择的潜在作用。
期刊介绍：
This peer-reviewed online-only journal publishes original case reports covering the entire spectrum of ophthalmology, including prevention, diagnosis, treatment, toxicities of therapy, supportive care, quality-of-life, and survivorship issues. The submission of negative results is strongly encouraged. The journal will also accept case reports dealing with the use of novel technologies, both in the arena of diagnosis and treatment. Supplementary material is welcomed. The intent of the journal is to provide clinicians and researchers with a tool to disseminate their personal experiences to a wider public as well as to review interesting cases encountered by colleagues all over the world. Universally used terms can be searched across the entire growing collection of case reports, further facilitating the retrieval of specific information. Following the open access principle, the entire contents can be retrieved at no charge, guaranteeing easy access to this valuable source of anecdotal information at all times.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
